Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03571828
Title Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications

mantle cell lymphoma

lymphoplasmacytic lymphoma

marginal zone B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

AMG562

Age Groups: senior | adult
Covered Countries USA | DEU | CAN | BEL

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
University of Maryland Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Wake Forest Baptist Health Winston-Salem North Carolina 27157 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Universitair Ziekenhuis Leuven - Campus Gasthuisberg Leuven 3000 Belgium Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Klinikum der Universität München Campus Großhadern München 81377 Germany Details
Universitatsklinikum Ulm Ulm 89081 Germany Details
Universitätsklinikum Würzburg Würzburg 97080 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field